BLUESPHERE BIO
BlueSphere Bio was founded to deploy its novel TCXpress technology to unlock the potential of personalized T-cell therapy for the treatment of cancer by harnessing the unique specificity of each patient’s own T-cells for the particular molecular fingerprint of each patient’s own cancer.
BLUESPHERE BIO
Social Links:
Industry:
Biotechnology Medical
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.bluespherebio.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Facebook Sharer Amazon Virginia Region Amazon SES CodeTwo CSC Global DNS
Similar Organizations
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Current Employees Featured
Founder
Official Site Inspections
http://www.bluespherebio.com Semrush global rank: 4.22 M Semrush visits lastest month: 2.8 K
- Host name: bluespherebio.tempurl.host
- IP address: 104.207.132.166
- Location: Piscataway United States
- Latitude: 40.5511
- Longitude: -74.4606
- Metro Code: 501
- Timezone: America/New_York
- Postal: 08854
More informations about "BlueSphere Bio"
About Us | BlueSphere Bio
Cookie Duration Description; _ga: 2 years: The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's …See details»
BlueSphere Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] BlueSphere Bio was founded to deploy its novel TCXpress technology to unlock the potential of …See details»
BlueSphere Bio - LinkedIn
BlueSphere Bio was founded to unlock the potential of personalized T cell therapy for the treatment of cancer by harnessing the unique specificity of each patient’s own T cells for the ...See details»
BlueSphere Bio - Overview, News & Similar companies - ZoomInfo
View BlueSphere Bio (www.bluespherebio.com) location in Pennsylvania, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
BlueSphere Bio - BIO CEO & Investor Conference | BIO
Feb 7, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. BlueSphere …See details»
BlueSphere Bio To Partner with NMDP BioTherapies℠ for the …
PITTSBURGH, June 25, 2024 (GLOBE NEWSWIRE) — BlueSphere Bio, a drug development company focused on novel T-cell receptor (TCR) based therapies for oncology and non …See details»
BlueSphere Bio, Inc. (BlueSphere Bio, Inc.) - 药物管线_专利_临床试 …
May 1, 2023 Company ContactKim JaffeSenior Vice President, Head of Business Development & Strategy+1- [email protected] Media ContactAndrew MielachLifeSci …See details»
BlueSphere Bio - BIO International Convention 2025
Jun 4, 2024 BlueSphere Bio is leveraging its TCR discovery platform, TCXpress™, to develop a portfolio of TCR-based assets with an initial clinical focus on high-risk leukemias (AML, ALL, …See details»
BlueSphere Bio - Craft
BlueSphere Bio is a company that develops personalized T-cell therapies for cancer. Its proprietary TCXpress technology platform stimulates the patient’s own immune defenses to …See details»
News | BlueSphere Bio
Aug 14, 2024 Cookie Duration Description; _ga: 2 years: The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report.See details»
BlueSphere Bio Announces IND Clearance of its First in Human …
Jun 3, 2024 TCX-101 Clinical Program: TCR T-Cell therapy product candidate (BSB-1001) to be delivered simultaneously with allogeneic stem cell transplant in patients with active disease or …See details»
BlueSphere Bio - workinbiotech.com
BlueSphere Bio is personalizing T-cell therapies for the treatment of cancer. As every cancer is unique, BlueSphere believes so should therapies. BlueSphere is enabling each patient’s …See details»
About Us | BlueSphere Bio
Every cancer is unique, so therapies should be too BlueSphere Bio was founded to enable each patient’s immune system to provide the ability to create their ...See details»
BlueSphere Bio Names Immune Oncology Pioneers to Scientific …
He is a well-recognized expert on T cells, with work that spans T cell receptors, activation and memory formation to the discovery that most T cells are outside of lymphoid organs. Jenkins is …See details»
BlueSphere Bio to Present a Corporate Overview at the 2022 BIO ...
PITTSBURGH, June 13, 2022 (GLOBE NEWSWIRE) -- BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company developing a powerful TCR discovery platform and novel therapeutic …See details»
BlueSphere Bio to Present a Corporate Overview at the 2022
PITTSBURGH, June 13, 2022 (GLOBE NEWSWIRE) -- BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company developing a powerful TCR discovery platform and novel therapeutic …See details»
BlueSphere Bio Establishes Strategic Collaboration with the
Jun 4, 2024 [email protected]. BlueSphere Media Contact Andrew Mielach LifeSci Communications +1-646-876-5868 [email protected] ...See details»
BlueSphere Bio Appoints Keir Loiacono as Chief Executive
Oct 4, 2022 [email protected]. Media Contact Andrew Mielach LifeSci Communications +1-646-876-5868 [email protected] ...See details»
BlueSphere Bio to Present a Corporate Overview at the 2022 BIO ...
PITTSBURGH, PA, June 13, 2022 — BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company developing a powerful TCR discovery platform and novel therapeutic candidates for …See details»
Establishing Canada’s first large-scale bioinnovation centre
4 days ago The Neptune BioInnovation Centre (NBC), a 51,000 sq ft facility on a 12.3 acre lot in Dartmouth, will offer leasable wet and dry lab space, warehouse and office spaces, and …See details»